Glasgow @profBigG delivered. Congratulations all #IMS26 @Myeloma_Society
Excited to 👀all next yr at 🐘🇮🇳
Nursing & Allied Health welcome colleagues to contribute and be part of ongoing improved pt outcomes @mmamynurse @marymyeloma @Bethfaiman @domenica76 @RahulBanerjeeMD
Thank you to everyone who joined #IMS26, both in person and virtually. Save the date for next year’s meeting, taking place September 29–October 2 in New Delhi, India. We look forward to seeing you in 2027!
Thats a wrap #IMS26
PERSEUS up front SOC- BsAB come forward-fixed duration therapies-looking forward to cure-InVivoCART ahead.
Thats a wrap #IMS26
PERSEUS up front SOC- BsAB come forward-fixed duration therapies-looking forward to cure-InVivoCART ahead.
Is this you @DrRakeshPopat ?
Meet the next generation of myeloma health care professionals! #IMS26 @HealthTree
Bumped into @DrRakeshPopat @profBigG post @Myeloma_Society #IMS26 night after @chillipipers
New approach to #mmsm. @RahulBanerjeeMD are you in there!?
Delighted to hear pt org panel #IMS26 mention valuable role of #nurses to outcomes of those with #mm. Thank-you to #IMS26 for ongoing support of Nursing & Allied Health Symposium - strong desire to increase length / opportunities here. @Bethfaiman @mmamynurse @marymyeloma
Important to see impressive work of pt groups at #IMS26 demonstrating their work to improving outcomes for those living with MM @IMFmyeloma @MyelomaUK @MyelomaEurope MMRF and @MyelomaAust_MFA
Impressive - yet Dara not universally available 🌎🌍- take NZ as example - no access to Dara in any line!! #MMsM must continue to work towards IMPROVING access so all people can benefit from increased LIFE @MyelomaNZ @LBCNZ
#IMS26 #mmsm Plenary
Long term follow up PERSEUS
➡️Median follow up ~7 years Dara-RVD showed better PFS of 81% vs. 56% with better MRD negativity at both 10-5 and 10-6 sensitivity thresholds (lower numbers with high risk disease)
➡️~ 3 out of 4 DVRd-DR patients receiving maintenance achieved 12-month sustained MRD negativity, with subsequent discontinuation of daratumumab
OS still not statistically different
Amazing long therapy results with Quad induction, transplant and maintenance therapy
Tracy King retweeted
We should prioritize quality of life (QoL) as an endpoint in MM clinical trials, especially in high-risk patients --- Karthik Ramasamy, MD, PhD. He presented QoL data from the RADAR trial in newly diagnosed pts w/ ultra high-risk MM. #IMS26
❤️catching up with International 🇬🇧 #NAH friends at #IMS26. Collaborations @MyelomaUK @hsanz_org_au and friendships
Regionally appropriate 🇦🇺🐨consensus optimal delivery of BsAB @hsanz_org_au with expert Int review from 🇺🇸 @IMFmyeloma @Bethfaiman @marymyeloma Sam Shenoy
BsAB in OP setting supported by careful pt selection, CRS mitigation and immune surveillance/prophylaxis. Thanks Landgren/Seymour/Kowalski/Hankey for session #IMS26
See poster NSP-06 today @hsanz_org_au for 🇦🇺🦘consensus @marymyeloma @Bethfaiman
Could this be the new target for 🏴#mmsm therapy - Girders against MM? #downwithdex #upwithirnbru
@RahulBanerjeeMD @Bethfaiman @profBigG @DrRakeshPopat @marymyeloma @mmamynurse
BsAB in OP setting supported by careful pt selection, CRS mitigation and immune surveillance/prophylaxis. Thanks Landgren/Seymour/Kowalski/Hankey for session #IMS26
See poster NSP-06 today @hsanz_org_au for 🇦🇺🦘consensus @marymyeloma @Bethfaiman
Nice work from @DrRakeshPopat and UK Myeloma Society ProMMise D trial testing use of PROM tool VRAT to assess ocular toxicity in #BelMaf and potential to avoid formal ocular exams.
Congratulations to Grace Reins and Huntsman Cancer Centre colleagues @marymyeloma for winning inaugural Best Abstract Award at #IMS26 NAH 🥇Project ECHO - Building Specialty Capacity in Rural Health - readily translatable @mmamynurse @Bethfaiman
#IMSNAH26 kicks off wed am events.jspargo.com/ims26/CUS…
👀you there @marymyeloma @mmamynurse @Bethfaiman @domenica76 @RahulBanerjeeMD
Don’t forget your passport! ✈️🌎Everything you need to know before heading to Glasgow can be found here➡️ow.ly/izUW50ZPIYj
Very important work - applicable to 🌏especially those of us 🇦🇺🦘with few ATCs, vast land mass (larger than USA) & large areas with low pop. More of this please Blue et al and my USA buddies @RahulBanerjeeMD @Bethfaiman @domenica76 and @marymyeloma I 👀your challenges!
…..and don’t get me started on our cousin 🇳🇿@MyelomaNZ @LBCNZ significant challenges in accessing even SOC drugs for #MMs - this needs to change now. Thanks for ongoing hard work @MyelomaAmarc @ALLGtrials @IMFmyeloma @MyelomaAust_MFA
3% of Australians donate 🩸🩸in Australia - 14th June is World Blood Donor.
Please consider donating as able - its a small step in your day - but helps save lives. @SydneyLHD TeamHaem dropped off a few pints yesterday @lifebloodau Marrickville










































